UNSPSC 85641963: Extirpation of matter from left foot subcutaneous tissue and fascia, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to extirpation of matter from left foot subcutaneous tissue and fascia, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JCR0ZZ

UNSPSC 85641963 Extirpation of matter from left foot subcutaneous tissue and fascia, open approach, is a Commodity code whose nominal clinical scope bears no relation to the state and local opportunities recently posted under it. The recent solicitations cover occupational medical surveillance, disability medical evaluation services, surgical benefit program management, pharmacy benefit administration, temporary health professional staffing, and emergency medical services for detained youth — none involving surgical extirpation of foot tissue. The code shows a clear classification mismatch and carries no decision-relevant procurement signal under its stated scope.

Issuing bodies posting under this code include city retirement offices (City of Phoenix), municipal health benefit administrators (City of Long Beach), state transportation departments (Washington State Department of Transportation), county juvenile justice systems (Harris County), county human resources divisions (Collier County), and county health systems (Santa Clara). Representative recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026, maximum contract value $750,000 over five years), the Washington State Department of Transportation's RFP for occupational medical surveillance services (RFP20260825, due October 9, 2026, two-year term with optional five-year extensions), and the City of Long Beach's RFP for surgical and medical procedure carve-out benefits (HR26753, due October 7, 2026, targeting April 2027 implementation). Geographic activity spans Arizona, California, and Washington, with additional activity in Florida and Texas. No vendor should treat this code as actionable for its stated clinical scope; the discrepancy suggests either a data-entry error in the procurement system or systematic miscoding that renders the code unreliable for business development targeting.